A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward defining the genetics of bladder cancer, and implies there may be at least two distinct genetic types of the disease.
Panel: Time is now for U.S. to lead in biomedical research
September 9, 2014 · No comments
The United States is in danger of losing its biomedical edge to countries that are...
At the CU Cancer Center Fall Retreat 2014, Allen S. Lichter, MD, FASCO, CEO of ASCO, points the way toward the future of oncology in 2030
National Clinical Trial Tests Power of COXEN Model to Predict Best Treatment for Bladder Cancer
August 13, 2014 · Comments Off
COXEN, a computer model that suggests treatment based on cancer genetics, is being tested in a new clinical trial, here at the CU Cancer Center and nationally via clinical sites of the Southwest Oncology Research Group.
“Treatments Waiting to be Discovered” Inside New Database
August 5, 2014 · Comments Off
University of Colorado Cancer Center database, multiMiR, allows researchers to search microRNA, gene, disease, and drug interactions.
Whedon Cancer Detection Foundation grants $100k for bladder cancer research
August 1, 2014 · Comments Off
University of Colorado Cancer Center Director Dan Theodorescu, MD, PhD, recently received a $103,165 grant...
Major Genetic Study Links Liver Disease Gene to Bladder Cancer
April 4, 2014 · Comments Off
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented tomorrow at the American Association for Cancer Research Annual Conference 2014) details the discovery of a new genetic driver of bladder cancer: silencing of the gene AGL.
Lung and bladder cancers have common cell-cycle biomarkers
January 29, 2014 · Comments Off
CU Cancer Center study: bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle.
Different parents, different children: Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells
December 17, 2013 · Comments Off
A CU Cancer Center study published today in the journal Stem Cells shows that progenitor cells that create dangerous, muscle-invasive bladder cancer are different than the progenitor cells that create non-muscle invasive bladder cancer. Though these two cancers grow at the same site, they are different diseases.
Bitter melon juice prevents pancreatic cancer in mouse models
December 17, 2013
NTRK1: a new oncogene and target in lung cancer
December 17, 2013
NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
September 30, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Another fantastic article by our guest blogger Celia Ruiz Tomlinson. fb.me/2HHwiDGD0
CU Cancer Center researcher looks into female sexual health after cancer treatment. “This is a subject that no... fb.me/6OkYVDAdD
Race for the Cure is tomorrow! We hope to see you there! fb.me/6BZ6FkEi0